Urolithin A vs Inflammaging: The Liver “Brake” Protein That UA Protects (NR77)

Mar 23, 2026

A deep mechanistic dive into how a gut-derived metabolite may protect the aging liver by preserving a key anti-inflammatory brake protein. They unpack ubiquitination, proteasomal loss, and MDM2’s role in NR77 degradation. Experiments in macrophage models and an aging-like mouse study are described. Caveats about preprint status, model limits, and translational uncertainty are highlighted.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

INSIGHT

NUR-77 Acts As An Anti-Inflammatory Brake

NUR-77 (NR4A1) is an orphan nuclear receptor that regulates inflammation, oxidative stress, autophagy, and cell fate and declines with age.
Loss of NUR-77 weakens inflammatory regulation, making it a 'brake' whose failure promotes inflammaging.

INSIGHT

UA Stabilizes NUR-77 By Preventing Ubiquitination

The proposed mechanism is post-translational: aging stress raises MDM2 which ubiquitinates NUR-77, sending it to the proteasome for degradation.
Urolithin A appears to block that ubiquitination, stabilizing NUR-77 protein without raising its mRNA.

INSIGHT

UA Reverses Macrophage Senescence Signatures

In RAW264.7 macrophages, D-galactose induces senescence markers (SA-β-gal, P53, P21, cytochrome C) and cytokine shifts (IL-6↑, IL-1β↑, IL-10↓).
Urolithin A at 10 µM reduces senescence staining and suppresses P53/P21 and pro-inflammatory cytokines while raising IL-10.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

Aging isn’t just time, it’s immune balance drifting out of control, and one of the most consistent signatures is inflammaging: chronic, low-grade inflammation that never fully resolves. This Deep Dive breaks down a mechanistic paper proposing that urolithin A (UA), a gut-derived metabolite linked to mitochondrial quality control, may protect the aging liver by stabilizing a key anti-inflammatory regulator: NR77 (NR4A1).

Instead of claiming UA “reduces inflammation” in a generic way, this study argues something sharper: aging-like stress increases MDM2, an E3 ubiquitin ligase that tags NR77 for proteasomal destruction. UA appears to reduce NR77 ubiquitination, preserve NR77 protein levels (without changing NR77 mRNA), suppress senescence markers (P53/P21), and shift cytokines toward inflammatory homeostasis (IL-6↓, IL-1β↓, IL-10↑) in both macrophage senescence and a D-galactose aging-like mouse model.

Important note: the work is described as a preprint (promising, mechanistically coherent, but needs peer review/replication).

(Educational content only, not medical advice.)

Article Discussed in Episode:

Urolithin A Attenuates Aging-Induced Liver Injury by Inhibiting Nur77 Ubiquitination Degradation

Key Quotes From Dr. Mike:

“Aging isn’t just getting older, it’s immune balance drifting out of control.”

"Inflammaging isn’t a flare-up. It’s the slow burn that drives chronic disease.”

“NR77 is like a braking system. Aging is what happens when the brakes fade.”

"UA (Urolithin A) doesn’t just ‘reduce inflammation’—it restores inflammatory homeostasis.”

“UA’s move is upstream: less ubiquitination, less degradation, more NR77.”

“Longevity is energy plus immune resolution plus cellular housekeeping.”

Key Points

Inflammaging = chronic inflammation that drives aging-related disease.
The liver is a central aging ogrgan (metabolism + immune signaling hub).
UA is a microbiome-derived metabolite (from ellagitannins/ellagic acid foods) with links to mitochondrial quality control.
The paper focuses on NR77 (NR4A1): a protective nuclear receptor involved in inflammation regulation (and potentially mitochondrial quality control via localization).
Core claim: UA doesn’t “boost NR77 gene expression”—it stabilizes NR77 protein.
Aging-like stress (D-gal) → MDM2↑ → NR77 ubiquitination↑ → NR77 degradation↑ → senescence/inflammation worsen.
In macrophages: D-gal ↑ SA-β-gal, P53/P21, IL-6/IL-1β; ↓ IL-10. UA reverses.
NR77 knockdown blocks UA benefits, suggesting NR77 is a mediator (not just a marker).
Proteasome inhibitor MG132 rescues NR77; UA’s effect is consistent with acting along the proteasome degradation pathway.
In vivo (D-gal mice): UA improves liver histology, ALT/AST, lipids (TG/TC), cytokine balance, and restores NR77↑ / MDM2↓.
Energy Code takeaway: longevity isn’t only ATP — it’s immune resolution + cellular housekeeping + protein stability.
Caveats: D-gal ≠ natural aging; RAW264.7 ≠ primary human macrophages; dosing/translation needs validation.

Episode timeline

0:19–1:45 — Aging = inflammaging; why the liver is central
1:50–3:09 — Paper framing + plan (UA, NR77, models, findings)
3:14–4:47 — UA basics + NR77 as an anti-inflammatory regulator that declines with age
4:58–6:36 — Hypothesis: UA stabilizes NR77 by reducing ubiquitination/degradation (MDM2 angle)
6:38–9:40 — Cell model (RAW264.7 + D-gal): senescence markers + cytokine shifts restored by UA
9:45–12:28 — Why NR77 matters: GEO rationale, docking (hypothesis), NR77 protein rescue, siRNA dependency
12:02–13:04 — Proteasome pathway evidence (MG132) + NR77 ubiquitination assay
13:08–14:29 — MDM2 implicated (up with D-gal, down with UA; interaction/localization evidence)
14:31–17:05 — In vivo D-gal mice: phenotype + liver histology + ALT/AST + TG/TC + cytokines + NR77/MDM2 axis
17:11–18:40 — Bigger nuance: senescence = SASP; NR77 localization may link to mitophagy/mitochondria
18:40–19:25 — Caveats (preprint; model limitations; translation questions)
19:31–23:35 — Energy Code takeaways + closing summary

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

Stay up-to-date on social media:

Dr. Mike Belkowski:

BioLight: